Nectar Lifescience Ltd
Nectar Lifesciences a pharmaceutical company, primarily engages in the development, manufacture, and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.
- Market Cap ₹ 451 Cr.
- Current Price ₹ 20.1
- High / Low ₹ 30.0 / 7.10
- Stock P/E
- Book Value ₹ 49.5
- Dividend Yield 0.25 %
- ROCE 8.31 %
- ROE 2.82 %
- Face Value ₹ 1.00
Pros
- Stock is trading at 0.41 times its book value
- Debtor days have improved from 84.57 to 61.14 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.60% over past five years.
- Company has a low return on equity of 4.06% for last 3 years.
- Dividend payout has been low at 2.68% of profits over last 3 years
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Mar 2006 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
80.41 | 530.80 | 723.87 | 732.61 | 795.68 | 575.33 | 578.68 | 647.96 | 564.76 | 389.62 | 427.97 | 378.00 | |
62.65 | 470.65 | 659.50 | 667.35 | 721.21 | 513.34 | 530.83 | 591.98 | 510.54 | 372.97 | 396.50 | 345.25 | |
Operating Profit | 17.76 | 60.15 | 64.37 | 65.26 | 74.47 | 61.99 | 47.85 | 55.98 | 54.22 | 16.65 | 31.47 | 32.75 |
OPM % | 22.09% | 11.33% | 8.89% | 8.91% | 9.36% | 10.77% | 8.27% | 8.64% | 9.60% | 4.27% | 7.35% | 8.66% |
Other Income | 2.75 | 1.31 | 1.45 | 1.53 | 1.66 | 2.13 | 1.19 | 0.58 | 0.11 | 0.52 | 0.53 | 0.66 |
Interest | 1.34 | 29.92 | 43.55 | 36.00 | 38.66 | 31.47 | 32.68 | 31.07 | 30.60 | 27.87 | 27.88 | 30.63 |
Depreciation | 2.90 | 16.29 | 15.55 | 16.88 | 14.54 | 16.40 | 13.77 | 15.23 | 15.36 | 15.05 | 15.09 | 15.10 |
Profit before tax | 16.27 | 15.25 | 6.72 | 13.91 | 22.93 | 16.25 | 2.59 | 10.26 | 8.37 | -25.75 | -10.97 | -12.32 |
Tax % | 9.47% | 12.92% | 12.35% | 21.64% | 23.64% | 15.63% | 5.41% | 19.98% | 11.35% | 34.33% | 33.36% | 34.50% |
Net Profit | 14.73 | 13.28 | 5.90 | 10.91 | 17.51 | 13.70 | 2.45 | 8.22 | 7.42 | -16.90 | -7.31 | -8.07 |
EPS in Rs | 0.99 | 0.59 | 0.26 | 0.49 | 0.78 | 0.61 | 0.11 | 0.37 | 0.33 | -0.75 | -0.33 | -0.36 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
725 | 843 | 1,060 | 1,312 | 1,622 | 1,634 | 1,638 | 1,674 | 1,635 | 1,874 | 2,779 | 2,363 | 1,760 | |
583 | 648 | 831 | 1,062 | 1,332 | 1,345 | 1,371 | 1,436 | 1,411 | 1,638 | 2,514 | 2,144 | 1,625 | |
Operating Profit | 141 | 195 | 229 | 250 | 290 | 289 | 267 | 239 | 224 | 236 | 264 | 220 | 135 |
OPM % | 19% | 23% | 22% | 19% | 18% | 18% | 16% | 14% | 14% | 13% | 10% | 9% | 8% |
Other Income | 3 | 19 | 12 | 12 | 16 | 12 | 20 | 6 | 23 | 6 | 6 | 4 | 2 |
Interest | 50 | 60 | 74 | 115 | 115 | 138 | 126 | 123 | 117 | 115 | 148 | 126 | 117 |
Depreciation | 30 | 39 | 46 | 61 | 76 | 84 | 77 | 57 | 62 | 64 | 63 | 61 | 61 |
Profit before tax | 64 | 115 | 120 | 85 | 115 | 78 | 85 | 64 | 67 | 63 | 59 | 37 | -41 |
Tax % | 17% | 20% | 13% | 14% | 25% | 21% | 22% | 15% | 18% | 17% | 19% | 15% | |
Net Profit | 53 | 92 | 104 | 73 | 86 | 62 | 66 | 54 | 55 | 52 | 48 | 32 | -25 |
EPS in Rs | 3.48 | 4.12 | 4.65 | 3.26 | 3.82 | 2.77 | 2.95 | 2.42 | 2.47 | 2.33 | 2.12 | 1.42 | -1.11 |
Dividend Payout % | 3% | 4% | 2% | 3% | 3% | 4% | 3% | 4% | 2% | 2% | 2% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 8% |
3 Years: | 13% |
TTM: | -32% |
Compounded Profit Growth | |
---|---|
10 Years: | -9% |
5 Years: | -14% |
3 Years: | -17% |
TTM: | -159% |
Stock Price CAGR | |
---|---|
10 Years: | -2% |
5 Years: | -12% |
3 Years: | -14% |
1 Year: | 85% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 5% |
3 Years: | 4% |
Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | |
Reserves | 288 | 598 | 699 | 762 | 845 | 905 | 936 | 932 | 984 | 1,036 | 1,083 | 1,114 | 1,088 |
Borrowings | 704 | 601 | 648 | 1,043 | 879 | 858 | 925 | 962 | 878 | 955 | 903 | 779 | 783 |
278 | 259 | 443 | 293 | 527 | 609 | 628 | 640 | 696 | 710 | 696 | 718 | 641 | |
Total Liabilities | 1,286 | 1,480 | 1,813 | 2,121 | 2,274 | 2,394 | 2,510 | 2,556 | 2,581 | 2,724 | 2,705 | 2,633 | 2,535 |
526 | 627 | 736 | 858 | 914 | 948 | 934 | 906 | 881 | 852 | 825 | 785 | 765 | |
CWIP | 74 | 56 | 82 | 150 | 139 | 122 | 91 | 99 | 102 | 100 | 100 | 115 | 115 |
Investments | 1 | 21 | 5 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
685 | 777 | 989 | 1,113 | 1,221 | 1,324 | 1,485 | 1,551 | 1,597 | 1,771 | 1,780 | 1,733 | 1,654 | |
Total Assets | 1,286 | 1,480 | 1,813 | 2,121 | 2,274 | 2,394 | 2,510 | 2,556 | 2,581 | 2,724 | 2,705 | 2,633 | 2,535 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
132 | 55 | 44 | 165 | 361 | 255 | 144 | 169 | 199 | 65 | 239 | 285 | |
-182 | -146 | -169 | -234 | -99 | -90 | -60 | -77 | -18 | -29 | -26 | -33 | |
58 | 91 | 123 | 62 | -282 | -161 | -61 | -89 | -204 | -40 | -201 | -252 | |
Net Cash Flow | 8 | 0 | -2 | -7 | -20 | 4 | 23 | 3 | -23 | -4 | 12 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 13% | 15% | 15% | 13% | 13% | 12% | 11% | 10% | 10% | 9% | 10% | 8% |
Debtor Days | 84 | 96 | 107 | 85 | 79 | 84 | 99 | 107 | 112 | 119 | 73 | 61 |
Inventory Turnover | 1.87 | 1.54 | 1.72 | 1.79 | 1.90 | 1.70 | 1.58 | 1.55 | 1.45 | 1.73 | 2.61 | 2.06 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Feb
- Announcement under Regulation 30 (LODR)-Change in Directorate 13 Feb
- Financial Results For The Quarter And Nine Months Ended On December 31, 2020 13 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Feb
- Intimation Of Application For Declassification / Reclassification Of Persons Forming Part Of Promoter / Promoter Group To Public Category. 8 Feb
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2013 from nse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2011 from nse
- Financial Year 2010 from bse
- Financial Year 2010 from nse